Delivery Order SPE2DB20D6037-SPE2DB24FTWL2
Award Date
8/6/24
Potential Completion Date
8/7/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,724 contract is for the delivery of 100 capsules of the medication Vyvanse (70 mg) with an ultimate completion date of December 4, 2023. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,616.04, is for the delivery of 100 units of the 50 mg capsule form of the prescription drug Vyvanse. The contract is a firm fixed-price delivery order, with an ultimate completion date of May 9, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,370.43 firm fixed-price contract is for the supply of Vyvanse 50 mg capsules. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $5,141.66, is for the supply of Vyvanse 40 mg capsules to support the recurring pharmaceutical needs of military health facilities. The contract has a firm fixed price and no set-aside designation. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides a wide...
This is a firm fixed-price delivery order (SPE2DB20D6037|SPE2DB24FTVC9) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,724.00 award is for the supply of 4,564,218,067 units of the prescription drug VYVANSE 10 MG CAPSULE 100S. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which provides a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $18,459.75 contract is for the supply of 40 mg Vyvanse capsules to support the medical needs of military healthcare facilities. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its small business status to secure this direct federal award. DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,780.52 contract is for the delivery of 100 units of the prescription drug Vyvanse 10 mg capsules. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of 4,563,918 units of the pharmaceutical drug Vyvanse 20 mg capsules. The firm fixed-price contract is valued at $1,031.85 and has a period of performance through March 11, 2024. The award is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract SPE2DB24D2106 with DLA, which has a total ceiling value of up...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,313.77 contract is for the supply of 4566838310 VYVANSE 50 MG CAPSULE 100S, with a performance period through January 6, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $3,448, is for the delivery of 100 units of 20 milligram Vyvanse capsules. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. The IDC covers a wide...